Clinical course of ST elevation myocardial infarction and blood leptin levels

Autor:	P. B. Adamov, A. Yu. Lebedeva, I. G. Gordeev, N. A. Volov, V. A. Kokorin, N. N. Levchuk, S. L. Sofrina, E. A. Kochmareva
Jazyk:	ruština
Rok vydání:	2013
Předmět:	leptin risk factor predictor cardiovascular pathology myocardial infarction percutaneous coronary interventions chronic kidney disease diabetes mellitus Diseases of the circulatory (Cardiovascular) system RC666-701
Zdroj:	Российский кардиологический журнал, Vol 0, Iss 2, Pp 24-30 (2013)
Druh dokumentu:	article
ISSN:	1560-4071 2618-7620
DOI:	10.15829/1560-4071-2013-2-24-30
Popis:	Recently, researchers have been increasingly interested in the association between the incidence of cardiovascular events (such as myocardial infarction, MI) and leptin – an adipocyte-produced hormone, which normally is involved in the body mass regulation. Aim. To assess the role of leptin in the clinical course of acute myocardial infarction with ST segment elevation (STEMI) on ECG. Material and methods. The study included 89 men aged 23–77 years. All patients underwent coronary angiography (CAG) in the first 12 hours of STEMI. Based on the CAG findings, 80 patients underwent percutaneous coronary interventions (PCI). All participants were divided into two groups, based on the plasma levels of leptin. Group 1 (n=42) had elevated leptin levels (>5,63 ng/ml), while Group 2 (n=47) had normal leptin levels (
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/efe9c497502c411682fb4a213ad0faee Zobrazit plný text záznamu View record in DOAJ